โ† All Topics / eu-reg-2020-354-parnut

PARNUT Part B entries 10-30 (companion animals) x evidence-topic pairing map

parnut_evidence_pairing_companion

eu-reg-2020-354-parnut 950 tok en 2026-07-30

PARNUT Part B (companion animals) x evidence-topic pairing map

Cross-reference (2026-07-30). PARNUT = Commission Regulation (EU) 2020/354, Annex Part B. This map links the 21 companion-animal disease entries (numbers 10-30) to the existing evidence category topics that cover the same disease area. The two entries that previously had no matching evidence topic โ€” Entry 15 (nutritional restoration) and Entry 22 (hyperlipidaemia) โ€” now have dedicated first-hand Europe PMC evidence topics (see D6 gap-fill).

Every topic identifier and title below is a verbatim entry in web/topics/_index.json (this topic's declared source).

Entries 10-30 โ€” companion animals

  • Entry 10 โ€” renal function (EU_2020_354_entry_10_renal_function) pairs with: evidence_renal_diet, evidence_feline_chronic_kidney_disease_diet, evidence_canine_chronic_kidney_disease_diet, evidence_canine_renal_acute_diet, evidence_equine_renal_diet.
  • Entry 11 โ€” oxalate stones (EU_2020_354_entry_11_oxalate_stones) pairs with: evidence_canine_calcium_oxalate_urolith_diet.
  • Entry 12 โ€” glucose / diabetes (EU_2020_354_entry_12_glucose_diabetes) pairs with: evidence_canine_diabetes_diet, evidence_feline_diabetes_diet.
  • Entry 13 โ€” ingredient intolerances (EU_2020_354_entry_13_ingredient_intolerances) pairs with: evidence_canine_food_allergy_diet, evidence_feline_food_allergy_diet.
  • Entry 14 โ€” cystine stones (EU_2020_354_entry_14_cystine_stones) pairs with: evidence_canine_urolithiasis_urate_cystine.
  • Entry 15 โ€” nutritional restoration (EU_2020_354_entry_15_nutritional_restoration) pairs with: evidence_canine_feline_recovery_convalescence_diet (NEW D6 gap-fill โ€” Europe PMC first-hand).
  • Entry 16 โ€” urate stones (EU_2020_354_entry_16_urate_stones) pairs with: evidence_canine_urolithiasis_urate_cystine.
  • Entry 17 โ€” struvite dissolution (EU_2020_354_entry_17_struvite_dissolution) pairs with: evidence_canine_urolith_struvite_diet, evidence_feline_urolith_diet.
  • Entry 18 โ€” struvite recurrence (EU_2020_354_entry_18_struvite_recurrence) pairs with: evidence_canine_urolith_struvite_diet, evidence_feline_urolith_diet.
  • Entry 19 โ€” maldigestion (EU_2020_354_entry_19_maldigestion) pairs with: evidence_canine_epi_diet, evidence_canine_ibd_diet, evidence_feline_ibd_diet.
  • Entry 20 โ€” intestinal absorption (EU_2020_354_entry_20_intestinal_absorption) pairs with: evidence_canine_ibd_diet, evidence_feline_ibd_diet.
  • Entry 21 โ€” acute intestinal (EU_2020_354_entry_21_acute_intestinal) pairs with: evidence_canine_ibd_diet, evidence_feline_ibd_diet, evidence_feline_gastrointestinal_diet.
  • Entry 22 โ€” hyperlipidaemia (EU_2020_354_entry_22_hyperlipidaemia) pairs with: evidence_canine_feline_hyperlipidemia_diet (NEW D6 gap-fill โ€” Europe PMC first-hand).
  • Entry 23 โ€” liver function (EU_2020_354_entry_23_liver_function) pairs with: evidence_canine_hepatic_diet, evidence_feline_hepatic_lipidosis_diet, evidence_canine_hepatic_encephalopathy_diet, evidence_equine_liver_kidney_diet.
  • Entry 24 โ€” cardiac function (EU_2020_354_entry_24_cardiac_function) pairs with: evidence_canine_cardiac_diet, evidence_feline_cardiac_diet, evidence_canine_mitral_valve_disease_diet, evidence_feline_hcm_diet, evidence_dcm_diet.
  • Entry 25 โ€” weight reduction (EU_2020_354_entry_25_weight_reduction) pairs with: evidence_canine_obesity_weight_management, evidence_feline_obesity_weight.
  • Entry 26 โ€” skin dermatosis (EU_2020_354_entry_26_skin_dermatosis) pairs with: evidence_canine_atopic_dermatitis_diet, evidence_feline_atopic_dermatitis_diet, evidence_canine_skin_coat_diet, evidence_feline_skin_coat_diet.
  • Entry 27 โ€” osteoarthritis (EU_2020_354_entry_27_osteoarthritis) pairs with: evidence_joint_oa, evidence_equine_joint_arthritis_diet.
  • Entry 28 โ€” liver copper (EU_2020_354_entry_28_liver_copper) pairs with: evidence_canine_hepatic_diet (partial โ€” copper-specific management not separately covered).
  • Entry 29 โ€” hyperthyroidism (EU_2020_354_entry_29_hyperthyroidism) pairs with: evidence_feline_hyperthyroidism_diet, evidence_feline_hyperthyroidism_management.
  • Entry 30 โ€” stress behavior (EU_2020_354_entry_30_stress_behavior) pairs with: evidence_canine_cognitive_dysfunction_diet, evidence_feline_cognitive_dysfunction_diet, evidence_canine_anxiety_calm_nutrition.

Coverage summary

  • 21 companion-animal PARNUT entries (10-30) reviewed.
  • 19 entries have at least one pre-existing evidence topic; 2 entries (15, 22) had no match and were filled in D6 with first-hand Europe PMC evidence topics.
  • Entry 28 (liver copper) has only partial evidence coverage (copper-restricted hepatopathy diets are not yet a dedicated evidence topic) โ€” flagged for a future gap-fill.

Source: web/topics/_index.json (every topic_id and title above is a verbatim registered entry).

Sources

PARNUT Part B entries 10-30 (companion animals) x evidence-topic pairing map
Source document: petforai.com Topics Index (web/topics/_index.json) โ€” every paired topic_id and title below is a verbatim entry in the index
petforai.com Topics Indexweb/topics/_index.jsonretrieved 2026-07-30

Verification file: web/topics/_index.json